Homozygous deletion and frequent allelic loss of the 21q11.1-q21.1 region including the ANA gene in human lung carcinoma. 1998

T Kohno, and M Kawanishi, and S Matsuda, and H Ichikawa, and M Takada, and M Ohki, and T Yamamoto, and J Yokota
National Cancer Center Research Institute, Tokyo, Japan.

The frequent occurrence of 21q deletions in human non-small cell lung carcinoma (NSCLC) indicates the presence of a tumor suppressor gene on this chromosome arm. Since the ANA (Abundant in Neuroepithelium Area) gene, a member of an antiproliferative gene family, was mapped to 21q11.2-q21.1, we searched for genetic alterations of the ANA gene in human lung cancers. The gene was homozygously deleted in a human NSCLC cell line, Ma17. The gene was mapped in the 0.33 Mb Not1 fragment at 21q21.1 of the Not1 restriction map for 21q. Loss of heterozygosity (LOH) at this locus was detected in 24/47 (51.1%) of NSCLC, and the frequency of LOH in brain metastases was significantly higher than that in stage I-II primary tumors (P = 0.018). These results suggested that the homozygously deleted region harbors a novel tumor suppressor gene involved in NSCLC progression. Since mutation of the ANA gene was not detected in other lung cancer cell lines and fresh lung tumors with LOH at this locus, it is unlikely that the ANA gene is a target gene inactivated by two mutational events in this chromosomal region. Physical mapping of the homozygously deleted region showed that the deletion had occurred interstitially at 21q11.1-q21.1 and the size of the deletion was estimated as being more than 3 Mb. Our mapping results will facilitate further efforts to identify a tumor suppressor gene on 21q.

UI MeSH Term Description Entries
D007438 Introns Sequences of DNA in the genes that are located between the EXONS. They are transcribed along with the exons but are removed from the primary gene transcript by RNA SPLICING to leave mature RNA. Some introns code for separate genes. Intervening Sequences,Sequences, Intervening,Intervening Sequence,Intron,Sequence, Intervening
D008175 Lung Neoplasms Tumors or cancer of the LUNG. Cancer of Lung,Lung Cancer,Pulmonary Cancer,Pulmonary Neoplasms,Cancer of the Lung,Neoplasms, Lung,Neoplasms, Pulmonary,Cancer, Lung,Cancer, Pulmonary,Cancers, Lung,Cancers, Pulmonary,Lung Cancers,Lung Neoplasm,Neoplasm, Lung,Neoplasm, Pulmonary,Pulmonary Cancers,Pulmonary Neoplasm
D008297 Male Males
D002289 Carcinoma, Non-Small-Cell Lung A heterogeneous aggregate of at least three distinct histological types of lung cancer, including SQUAMOUS CELL CARCINOMA; ADENOCARCINOMA; and LARGE CELL CARCINOMA. They are dealt with collectively because of their shared treatment strategy. Carcinoma, Non-Small Cell Lung,Non-Small Cell Lung Cancer,Non-Small Cell Lung Carcinoma,Non-Small-Cell Lung Carcinoma,Nonsmall Cell Lung Cancer,Carcinoma, Non Small Cell Lung,Carcinomas, Non-Small-Cell Lung,Lung Carcinoma, Non-Small-Cell,Lung Carcinomas, Non-Small-Cell,Non Small Cell Lung Carcinoma,Non-Small-Cell Lung Carcinomas
D002891 Chromosomes, Human, Pair 21 A specific pair of GROUP G CHROMOSOMES of the human chromosome classification. Chromosome 21
D005091 Exons The parts of a transcript of a split GENE remaining after the INTRONS are removed. They are spliced together to become a MESSENGER RNA or other functional RNA. Mini-Exon,Exon,Mini Exon,Mini-Exons
D006023 Glycoproteins Conjugated protein-carbohydrate compounds including MUCINS; mucoid, and AMYLOID glycoproteins. C-Glycosylated Proteins,Glycosylated Protein,Glycosylated Proteins,N-Glycosylated Proteins,O-Glycosylated Proteins,Glycoprotein,Neoglycoproteins,Protein, Glycosylated,Proteins, C-Glycosylated,Proteins, Glycosylated,Proteins, N-Glycosylated,Proteins, O-Glycosylated
D006720 Homozygote An individual in which both alleles at a given locus are identical. Homozygotes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

T Kohno, and M Kawanishi, and S Matsuda, and H Ichikawa, and M Takada, and M Ohki, and T Yamamoto, and J Yokota
May 2005, Cancer genetics and cytogenetics,
T Kohno, and M Kawanishi, and S Matsuda, and H Ichikawa, and M Takada, and M Ohki, and T Yamamoto, and J Yokota
September 1993, Cancer research,
T Kohno, and M Kawanishi, and S Matsuda, and H Ichikawa, and M Takada, and M Ohki, and T Yamamoto, and J Yokota
January 1999, International journal of cancer,
T Kohno, and M Kawanishi, and S Matsuda, and H Ichikawa, and M Takada, and M Ohki, and T Yamamoto, and J Yokota
September 2011, Oncogene,
T Kohno, and M Kawanishi, and S Matsuda, and H Ichikawa, and M Takada, and M Ohki, and T Yamamoto, and J Yokota
April 1999, Genomics,
T Kohno, and M Kawanishi, and S Matsuda, and H Ichikawa, and M Takada, and M Ohki, and T Yamamoto, and J Yokota
February 2001, Genomics,
T Kohno, and M Kawanishi, and S Matsuda, and H Ichikawa, and M Takada, and M Ohki, and T Yamamoto, and J Yokota
April 1994, Cancer research,
T Kohno, and M Kawanishi, and S Matsuda, and H Ichikawa, and M Takada, and M Ohki, and T Yamamoto, and J Yokota
May 1999, International journal of cancer,
T Kohno, and M Kawanishi, and S Matsuda, and H Ichikawa, and M Takada, and M Ohki, and T Yamamoto, and J Yokota
January 1998, International journal of oncology,
T Kohno, and M Kawanishi, and S Matsuda, and H Ichikawa, and M Takada, and M Ohki, and T Yamamoto, and J Yokota
February 2006, International journal of oncology,
Copied contents to your clipboard!